Complement activation and regulator expression after anoxic injury of human endothelial cells

APMIS

Volumn 106, Issue 12, 1998, Pages 1149-1156

  Vakeva A ^a,b   Meri, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Complement regulation; Flow cytometry; Ischemia reperfusion injury

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; HEPARIN COFACTOR;

ANOXIA; ARTICLE; COMPLEMENT ACTIVATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; REPERFUSION INJURY;

EID: 0032451325     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00271.x     Document Type: Article

References (49)

1. Brooimans, R. A., van der Ark, A. A. J., Tomita, M., van Es, L.A. & Daha, M. R.: CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Eur. J. Immunol. 22: 791-797, 1992.
2. Brooimans, R. A., van Wieringen, P., van Es, L. A. & Daha, M. R.: Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur. J. Immunol. 22: 3135-3140, 1992.
3. Buerke, M., Murohara, T. & Lefer, A. M.: Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91: 393-402, 1995.
4. Cole, J., Housley, G. A., Dykman, T. R., MacDermott, R. P. & Atkinson, J. P.: Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc. Natl. Acad. Sci. USA 82: 859-864, 1986.
5. Collard, C. D., Väkevä, A., Bukusoglu, C., Zund, G., Colgan, S. P. & Stahl, G. L.: Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96: 326-333, 1997.
6. Crawford, M. H., Grover, F. L., Kolb, W. P., McMahan, C. A., O'Rourke, R. A., McManus, L. M. & Pinckard, R. N.: Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78: 1449-1458, 1988.
7. Davies, A., Simmons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J. & Waldmann, H.: CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170: 637-654, 1989.
8. Edgell, C. J. S., McDonald, C. G. & Graham, J. B.: Permanent cell line expressing factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80: 3734-3739, 1983.
9. Entman, M. L., Michael, L., Rossen, R. D., Dreyer, W. J., Anderson, D. C., Taylor, A. A. & Smith, C. W.: Inflammation in the course of early myocardial ischemia. FASEB J. 5: 2529-2537, 1991.
10. Entman, M. L. & Smith, C. W.: Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc. Res. 28: 1301-1311, 1994.
11. Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M. & Ward, P. A.: C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94: 1147-1155, 1994.
12. Friedman, M., Wang, S. Y., Stahl, G. L., Johnson, R. G. & Sellke, F. W.: Altered beta-adrenergic and cholinergic pulmonary vascular responses after total cardiopulmonary bypass. J. Appl. Physiol. 79: 1998-2006, 1995.
13. Gottlieb, R. A., Burleson, K. O., Kloner, R. A., Bablor, B. M. & Engler, R. L.: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94: 1621-1628, 1994.
14. Hugli, T. E.: Structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 7: 193-219, 1984.
15. Hugo, F., Hamdoch, T., Mathey, D., Schäfer, H. & Bhakdi, S.: Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium. Clin. Exp. Immunol. 81: 132-136, 1990.
16. Jones, J. & Morgan, B. P.: Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 86: 651-660, 1995.
17. Kagiyama, A., Savage, H. E., Michael, L. H., Hansson, G., Entman, M. L. & Rossen, R. D.: Molecular basis of complement activation in ischemic myocardium: identification of specific molecules of mitochondrial origin that bind human C1q and fix complement. Circ. Res. 64: 607-615, 1989.
18. Kajstura, J., Cheng, W., Reiss, K., Clark, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J. C., Olivetti, G. & Anversa, P.: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74: 86-107, 1996.
19. Kilgore, K. S., Miller, B. F., Imlay, M. M. & Warren, J. S.: P-selectin and PAF-dependent neutrophil adhesion to endothelial cells is induced by the membrane attack complex (MAC). FASEB J. 9: A35 (Abstract), 1995.
20. Lennon, P. F., Collard, C. D., Morrissey, M. A. & Stahl, G. L.: Complement-induced endothelial dysfunction in rabbits: mechanism, recovery, and gender differences. Am. J. Physiol. 270: H1924-1932, 1996.
21. Linder, E., Lehto, V. P. & Stenman, S.: Activation of complement by cytoskeletal intermediate filaments. Nature 278: 176-178, 1979.
22. Lucchesi, B. R.: Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 24: 41-47, 1993.
23. Marks, R. M., Todd, R. F. I. & Ward, P. A.: Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 339: 314-317, 1989.
24. Maroko, P. R., Carpenter, C. B., Chiariello, M., Fishbein, M. C., Randvany, P., Kostman, J. D. & Hale, S. L.: Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 61: 661-670, 1978.
25. Mathey, D., Schofer, J., Schäfer, H. J., Hamdoch, T., Joachim, H. C., Ritgen, A., Hugo, F. & Bhakdi, S.: Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur. Heart. J. 15: 418-423, 1994.
26. Meri, S.: Protectin (CD59). Complement lysis inhibitor and prototype domain in a new protein superfamily. Immunologist 2: 93-99, 1994.
27. Meri, S., Mattila, P. & Renkonen, R.: Regulation of CD59 expression on the human endothelial cell line EA.hy 926. Eur. J. Immunol. 23: 2511-2516, 1993.
28. Meri, S. & Pangburn, M. K.: Discrimination between activators and nonactivators of alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986, 1990.
29. Meri, S. & Pangburn, M. K.: Regulation of alternative pathway complement activation by glycosaminoglycans: Specificity of the polyanion binding site on factor H. Biochem Biophys. Res. Comm. 198: 52-59, 1994.
30. Meri, S., Waldmann, H. & Lachmann, P. J.: Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab. Invest. 65: 532-537, 1991.
31. Morgan, B. P.: Complement. Clinical aspects and relevance to disease. First ed. Academic Press Ltd., London 1991.
32. Morgan, B. P. & Meri, S.: Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 15: 369-396, 1994.
33. Müller-Eberhard, H. J.: The membrane attack complex of complement. Annu. Rev. Immunol. 4: 503-528, 1986.
34. Pinckard, R. N., O'Rourke, R. A., Crawford, M. H., Grover, F. L., McManus, L. M., Ghidoni J. J., Storrs, S. B. & Olson, M. S.: Complement localization and mediation of ischemic injury in baboon myocardium. J. Clin. Invest. 66: 1050-1056, 1980.
35. Rossen, R. D., Michael, L. H., Hawkins, H. K., Dreyer, W. J., Baughn, R. E. & Entman, M. L.: Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ. Res. 75: 546-555, 1994.
36. Rossen, R. D., Michael, L. H., Kagiyama, A., Savage, H. E., Hanson, G., Reisberg, M. A., Moake, J. N., Kim, S. H., Self, D., Weakley, S., Giannini, E. & Entman, M. L.: Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ. Res. 62: 572-584, 1988.
37. Rossen, R. D., Swain, J. L., Michael, L. H., Weakley, S., Giannini, E. & Entman, M. L.: Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ. Res. 57: 119-130, 1985.
38. Rus, H. G., Niculescu, F. & Vlaicu, R.: Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis. Immunol. Lett. 16: 15-20, 1987.
39. Schäfer, H., Mathey, D., Hugo, F. & Bhakdi, S.: Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137: 1945-1949, 1986.
40. Smith, E. F., Griswold, D. E., Egun, J. W., Hillegaas, L. M., Smith, R. A., Hibbs, M. J. & Gagnon, R. C.: Reduction of myocardial reperfusion injury with human soluble complement receptor type I (BBL 55730). Eur. J. Pharmacol. 236: 477-481, 1993.
41. Stahl, G. L., Reenstra, W. R. & Frendl, G.: Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ. Res. 76: 575-583, 1995.
42. Tada, T., Okada, H., Okada, N., Tateyama, H. & Eimoto, T.: Expression of 20 KD homologous restriction factor of complement on myocardial cells: an immunohistochemical study using acetone-fixed and paraffin-embedded tissues. J. Histochem. Cytochem. 41: 119-122, 1993.
43. Tsuji, S., Kaji, K. & Nagasawa, S.: Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J. Biochem. 116: 794-800, 1994.
44. Väkevä, A., Laurila, P. & Meri, S.: Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab. Invest. 67: 608-616, 1992.
45. Väkevä, A., Laurila, P. & Meri, S.: Regulation of complement membrane attack complex formation in myocardial infarction. Am. J. Pathol. 143: 65-75, 1993.
46. Väkevä, A., Morgan, B. P., Tikkanen, I., Helin, K., Laurila, P. & Meri, S.: Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am. J. Pathol. 144: 1357-1368, 1994.
47. Vercellotti, G. M., Platt, J. L., Bach, F. H. & Dalmasso, A. P.: Neutrophil adhesion to xenogeneic endothelium via iC3b. J. Immunol. 146: 730-734, 1991.
48. Vogt, W.: Anaphylatoxins: Possible roles in disease. Compl. Inflamm. 78: 177-188, 1985.
49. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C. Jr., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, T. M. & Fearon, D. T.: Soluble human complement receptor type 1: in vivo inhibition of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151, 1990.